2020, Number 3
<< Back Next >>
Rev Biomed 2020; 31 (3)
Dry eye syndrome during climacteric in Mexican women
Rosales-Piñeyro J, González-Vazquez ME, López MOA, Sánchez-Sánchez AS
Language: Spanish
References: 14
Page: 134-138
PDF size: 555.08 Kb.
ABSTRACT
Introduction. Dry eye syndrome (DES) is a multifactorial disease
due to tear film defi ciency. It has been reported post-menopause latin
women present major incidence of it.
Aim. To know the percentage of DES grade 1 and 2 in Mexican women
during climacteric period at Instituto Nacional de Perinatología.
Material and method. A retrospective study supervised by department
of ophthalmology of Instituto Nacional de Perinatología was made
analyzing clinical records of women between 45 and 55 years, with
DES symptoms; quantity and quality tear fill test and bio-microscopic
examination.
Results. A marked increase of DES occurs in climacteric.
Conclusions. Mexican post-menopause women present major
frequency of dry eye disease.
REFERENCES
Javadi MA, Feizi S. Dry eye syndrome. J Ophthalmic Vis Res. 2011 Jul; 6(3): 192-8.
Thulasi P, Djalilian A. Update in current diagnostics and therapeutics of dry eye disease. Ophthalmology. 2017 Nov; 124 (11): 27-33. doi: 10.1016/j.ophtha.2017.07.022.
Salvador J. Climaterio y menopausia. Epidemiología y fisiopatogenia. Rev Per Ginecol Obstet. 2008 Apr-Jun; 54(2):71-8. doi: 10.31403/rpgo.v54i1092
Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric. 2010 Oct; 13(5):419-28. doi: 10.3109/13697137.2010.507886.
Ablamowicz AF, Nichols JJ, Nichols KK. Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women. Invest Ophthalmol Vis Sci. 2016 Feb; 57(2):295- 300. doi: 10.1167/iovs.15-18158
Golebiowski B, Badarudin N, Eden J, You J, Hampel U, Stapleton F. Does endogenous serum oestrogen play a role in meibomian gland dysfunction in postmenopausal women with dry eye? Br J Ophthalmol. 2017 Feb; 101(2):218-22. doi: 10.1136/bjophthalmol-2016-308473
Versura P, Giannaccare G, Campos EC. Sex-steroid imbalance in females and dry eye. Curr Eye Res. 2015 Feb; 40(2):162-75. doi: 10.3109/02713683.2014.966847
Carranza LS, Jimenez AM, Olhovich GI. Cambios oculares posteriores a la administración de tratamiento hormonal en mujeres posmenopáusicas. Reporte preliminar. Ginecol Obstet Mex. 2005 Apr; 73(4):194-7.
Bhavsar AS, Bhavsar SG, Jain SM. A review on recent advances in dry eye: Pathogenesis and management. Oman J Ophthalmol. 2011 May; 4(2):50-6. doi: 10.4103/0974-620X.83653
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (DEWS). Ocul Surf. 2007 Apr; 5(2):108-52. doi: 10.1016/S1542- 0124(12)70083-6
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun; 61(6):554- 8. doi: 10.1136/ard.61.6.554
Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003 Aug; 136(2):318-26. doi: 10.1016/ s0002-9394(03)00218-6
Agarwal R, Singh P, Rajpal T, Kumar R, Raghuwanshi S, Rammani V. Hospital based study of dry eye in postmenopausal women. Indian J Clin Exp Ophthalmol. 2016 Jan-March; 2(1):57-62. doi: 10.5958/2395- 1451.2016.00014.7
Pelit A, Bagis T, Kayaselcuk F, Dursun D, Akova Y, Aydin P. Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women. Eur J Ophthalmol. 2003 May;13(4):337-42.